Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Download Historical Drug Shortages
|
Contact Us
Start Over | Back to Search Results
Morphine Sulfate Injection
Status: Currently in Shortage
»Date first posted:
10/31/2017
»Therapeutic Categories: Analgesia/Addiction
Amphastar Pharmaceuticals, Inc. (Reverified 10/05/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Morphine Sulfate, Injection, 1 mg/1 mL (NDC 76329-1912-1) | Available |
Fresenius Kabi USA, LLC (Reverified 10/06/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Morphine Sulfate, Injection, 2 mg/1 mL (NDC 76045-004-11) | Unavailable | Next release September 2026. Check wholesalers for inventory. | Other |
| Morphine Sulfate, Injection, 4 mg/1 mL (NDC 76045-005-11) | Unavailable | Next release September 2026. Check wholesalers for inventory. | Other |
| Morphine Sulfate, Injection, 2 mg/1 mL (NDC 63323-452-01) | Unavailable | Next release September 2026. Check wholesalers for inventory. | Other |
| Morphine Sulfate, Injection, 4 mg/1 mL (NDC 63323-454-01) | Unavailable | Next release October 2026. Check wholesalers for inventory. | Other |
| Morphine Sulfate, Injection, 5 mg/1 mL (NDC 63323-455-01) | Unavailable | Estimated recovery: TBD | Demand increase for the drug |
| Morphine Sulfate, Injection, 10 mg/1 mL (NDC 63323-451-01) | Available | Check wholesalers for inventory |
Hikma Pharmaceuticals USA, Inc. (Reverified 09/18/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Duramorph, Injection, 1 mg/1 mL (NDC 0641-6019-10) | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | |
| Duramorph, Injection, .5 mg/1 mL (NDC 0641-6020-10) | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | |
| Infumorph 200 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 10 mg/1 mL (NDC 0641-6039-01) | Unavailable | Additional lots will be available in the October 2026 timeframe. Product will be made available as it is released. | Demand increase for the drug |
| Infumorph 500 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 25 mg/1 mL (NDC 0641-6040-01) | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | |
| Morphine Sulfate, Injection, 4 mg/1 mL (NDC 0641-6125-25) | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | |
| Morphine Sulfate, Injection, 8 mg/1 mL (NDC 0641-6126-25) | unavailable | Additional lots will be available in the October 2026 timeframe. Product will be made available as it is released. | Demand increase for the drug |
| Morphine Sulfate, Injection, 10 mg/1 mL (NDC 0641-6127-25) | Unavailable | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | Demand increase for the drug |
Hospira, Inc., a Pfizer Company (Revised 09/22/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Morphine Sulfate, Injection, 2 mg/1 mL (NDC 0409-1890-23) | Limited Availability | Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-2022-01) | Unavailable | Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| Morphine Sulfate, Injection, 2 mg/1 mL Syringes (NDC 0409-1890-01) | Available | ||
| Morphine Sulfate, Injection, 4 mg/1 mL Syringes (NDC 0409-1891-01) | Available | ||
| Morphine Sulfate, Injection, 10 mg/1 mL Syringes (NDC 0409-1893-01) | Unavailable | Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug |
| Morphine Sulfate, Injection, 5 mg/10 mL (0.5 mg/mL) (NDC 0409-3814-12) | Available | ||
| Morphine Sulfate, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-3815-12) | Available | ||
| Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1896-20) | Unavailable | Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
Piramal Critical Care Inc. (Revised 09/15/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Mitigo, Injection, 200 mg/20 mL (NDC 66794-160-02) | Available | ||
| Mitigo, Injection, 500 mg/20 mL (NDC 66794-162-02) | Available |